期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 較慢,6-12周

The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology (AMP), co-owned by the American Society for Investigative Pathology (ASIP), seeks to publish high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The editors welcome for review articles that contain: novel discoveries or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, clinical informatics, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods which may be applied to diagnosis or monitoring of disease or disease predisposition.

《分子診斷學(xué)雜志》是分子病理學(xué)協(xié)會(huì) (AMP) 的官方出版物，由美國(guó)病理學(xué)研究協(xié)會(huì) (ASIP) 共同擁有，旨在發(fā)表高質(zhì)量的原創(chuàng)論文，內(nèi)容涉及將醫(yī)學(xué)分子發(fā)現(xiàn)轉(zhuǎn)化為臨床診斷環(huán)境并加以驗(yàn)證的科學(xué)進(jìn)展，以及分子診斷醫(yī)學(xué)領(lǐng)域技術(shù)進(jìn)步的描述和應(yīng)用。編輯歡迎包含以下內(nèi)容的評(píng)論文章：新發(fā)現(xiàn)或臨床病理相關(guān)性，包括腫瘤學(xué)、傳染病、遺傳性疾病、疾病易感性、臨床信息學(xué)研究，或與疾病狀態(tài)或正常變異相關(guān)的多態(tài)性的描述；診斷方法在臨床試驗(yàn)中的應(yīng)用；或可用于診斷或監(jiān)測(cè)疾病或疾病易感性的新型或改良分子方法的開(kāi)發(fā)。

《Journal Of Molecular Diagnostics》(分子診斷雜志)編輯部通訊方式為AMER SOC INVESTIGATIVE PATHOLOGY, INC, 9650 ROCKVILLE PIKE, BETHESDA, USA, MD, 20814-3993。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。